Citadel Advisors
NBTX

Citadel Advisors’s Nanobiotix NBTX Stock Holding History

Citadel Advisors’s Portfolio NBTX Stock Details NBTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$228K Buy
+6,042
New +$225K ﹤0.01% 11762
2021
Q1 		– Sell
-32,556
Closed -$537K – 13539
2020
Q4 		$537K Buy
+32,556
New +$561K ﹤0.01% 8009

Other funds holding NBTX

JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Optiver Holding
Optiver Holding Amsterdam, Netherlands $371B AUM 64.6% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Citadel Advisors's NBTX Position: Q2 2026 in Review

Citadel Advisors opened a new position in Nanobiotix (NBTX) in Q2 2026: 6,042 shares worth $228K. The stake represents ﹤0.01% of the portfolio and ranks #11762 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in NBTX as recently as Q4 2020.

Citadel Advisors first reported a position in NBTX in Q4 2020 and has held it in 2 quarters since. The position peaked at $537K in Q4 2020. 19 funds tracked by Wall St. Rank hold NBTX as of Q2 2026.

  • Citadel Advisors held 6,042 shares of Nanobiotix worth $228K as of Q2 2026.
  • Nanobiotix was a new Citadel Advisors position in Q2 2026.
  • Nanobiotix made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #11762 holding.
  • Citadel Advisors first reported a position in Nanobiotix in Q4 2020 and has held it in 2 quarters since.
  • Citadel Advisors's Nanobiotix position peaked at $537K in Q4 2020.
  • 19 funds tracked by Wall St. Rank held Nanobiotix as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.